{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:28:21Z","timestamp":1791178101230,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1014416616687","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T20:35:40Z","timestamp":1041107740000},"page":"51-56","source":"Crossref","is-referenced-by-count":78,"title":["The IL-2\/IL-15 Receptor Systems: Targets for Immunotherapy"],"prefix":"10.1007","volume":"22","author":[{"given":"Thomas A.","family":"Waldmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"367779_CR1","first-page":"2825","volume":"58","author":"J Baselga","year":"1998","unstructured":"Baselga J, Norton L, Albanell J, et al: Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2\/neu overexpressing human breast cancer xenografts. Cancer Res 58:2825\u20132831, 1998","journal-title":"Cancer Res"},{"key":"367779_CR2","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-Lopez AJ, White CA, et al: IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low grade non-Hodgkin's lymphoma. Blood 90: 2188\u20132195, 1997","journal-title":"Blood"},{"key":"367779_CR3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jnci\/81.12.914","volume":"81","author":"TA Waldmann","year":"1989","unstructured":"Waldmann TA: Multichain interleukin-2 receptor: A target for immunotherapy in lymphoma. J Natl Cancer Inst 81:914\u2013923, 1989","journal-title":"J Natl Cancer Inst"},{"key":"367779_CR4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood.V72.5.1805.1805","volume":"72","author":"TA Waldmann","year":"1988","unstructured":"Waldmann TA, Goldman CK, Bongiovanni KF, et al: Therapy of patients with human T-cell lymphotrophic virus I induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood 72:1805\u20131816, 1988","journal-title":"Blood"},{"key":"367779_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.3008337","volume":"232","author":"T. A. Waldmann","year":"1986","unstructured":"Waldmann T A: The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science 232:727\u2013732, 1986","journal-title":"Science"},{"key":"367779_CR6","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","volume":"86","author":"TA Waldmann","year":"1995","unstructured":"Waldmann TA, White JD, Carrasquillo JA, et al: Radioimmunotherapy of IL-2R_-expressing adult T-cell leukemia with Yttrium-90 labeled anti-Tac. Blood 86:4063\u20134075, 1995","journal-title":"Blood"},{"key":"367779_CR7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ana.410440613","volume":"44","author":"TJ Lehky","year":"1998","unstructured":"Lehky TJ, Levin M, Kubota R, et al: Reduction in HTLV-1 proviral load and spontaneous lymphoproliferation in HTLV-1-associated myelopathy\/tropical spastic paraparesis patients treated with humanized anti-Tac Ann Neurol 44:942\u2013947, 1998","journal-title":"Ann Neurol"},{"key":"367779_CR8","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.96.13.7462","volume":"96","author":"RB Nussenblatt","year":"1999","unstructured":"Nussenblatt RB, Fortin E, Schiffman R, et al: Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac monoclonal antibody: A phase I\/II clinical trial. Proc Natl Acad Sci USA 96: 7462\u20137466, 1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood.V70.5.1407.1407","volume":"70","author":"M Maeda","year":"1987","unstructured":"Maeda M, Arima N, Daitoku Y, et al: Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 70:1407\u20131411, 1987","journal-title":"Blood"},{"key":"367779_CR10","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1073\/pnas.87.13.5218","volume":"87","author":"CL Tendler","year":"1990","unstructured":"Tendler CL, Greenberg SJ, Blattner WA, et al: Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 87:5218\u20135222, 1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR11","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","volume":"91","author":"JD Burton","year":"1994","unstructured":"Burton JD, Bamford RN, Peters C, et al: A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935\u20134939, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR12","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1073\/pnas.91.11.4940","volume":"91","author":"RN Bamford","year":"1994","unstructured":"Bamford RN, Grant AJ, Burton JD, et al: The interleukin (IL) 2 receptor (?) chain is shared by IL-2 and a cytokine, provisionally designated IL-T that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940\u20134944, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.8178155","volume":"264","author":"KH Grabstein","year":"1994","unstructured":"Grabstein KH, Eisenman J, Shanebeck K, et al: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965\u2013968, 1994","journal-title":"Science"},{"key":"367779_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","volume":"2","author":"JX Lin","year":"1995","unstructured":"Lin JX, Migone TS, Tsang M, et al: The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331\u2013339, 1995","journal-title":"Immunity"},{"key":"367779_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","volume":"17","author":"T Waldmann","year":"1999","unstructured":"Waldmann T, Tagaya Y: The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens, Annu Rev Immunol 17:19\u201349, 1999","journal-title":"Annu Rev Immunol"},{"key":"367779_CR16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","volume":"8","author":"X Zhang","year":"1998","unstructured":"Zhang X, Sun S, Hwang I, et al: Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15 Immunity 8:591\u2013599, 1998","journal-title":"Immunity"},{"key":"367779_CR17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.288.5466.675","volume":"288","author":"CC Ku","year":"2000","unstructured":"Ku CC, Murakami M, Sakamoto A, et al: Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288: 675\u2013678, 2000","journal-title":"Science"},{"key":"367779_CR18","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","volume":"97","author":"J Marks-Konczalik","year":"2000","unstructured":"Marks-Konczalik J, Dubois S, Losi JM, et al: IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 97:11445\u201311450, 2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR19","first-page":"105","volume":"14","author":"TA Waldmann","year":"2001","unstructured":"Waldmann TA, Dubois S, Tagaya Y: Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes; implications for immunotherapy. Immunity 14:105\u2013110, 2001","journal-title":"Immunity"},{"key":"367779_CR20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.126.4.1393","volume":"126","author":"T Uchiyama","year":"1981","unstructured":"Uchiyama, T, Broder S, Waldmann TA: A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol 126:1393\u20131397, 1981","journal-title":"J. Immunol"},{"key":"367779_CR21","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1073\/pnas.83.24.9694","volume":"83","author":"M Tsudo","year":"1986","unstructured":"Tsudo M, Kozak RW, Goldman CK, Waldmann TA: Demonstration of a non-Tac peptide that binds interleukin 2: A potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci USA 83:9694\u20139698, 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR22","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1126\/science.8266076","volume":"262","author":"M Kondo","year":"1993","unstructured":"Kondo M, Takeshita T, Ishii N, et al: Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874\u20131877, 1993","journal-title":"Science"},{"key":"367779_CR23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1126\/science.8266077","volume":"262","author":"M Noguchi","year":"1993","unstructured":"Noguchi M, Nakamura Y, Russell SM, et al: Interleukin-2 receptor chain: A functional component of the interleukin-7 receptor. Science 262:1877\u20131880, 1993","journal-title":"Science"},{"key":"367779_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","volume":"269","author":"TS Migone","year":"1995","unstructured":"Migone TS, Lin JX, Cereseto A, et al: Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269:79\u201381, 1995","journal-title":"Science"},{"key":"367779_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1172\/JCI119258","volume":"99","author":"WE Carson","year":"1997","unstructured":"Carson WE, Fehniger TA, Haldar S, et al: A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99:937\u2013943, 1997","journal-title":"J Clin Invest"},{"key":"367779_CR26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4049\/jimmunol.154.2.483","volume":"154","author":"RJ Armitage","year":"1995","unstructured":"Armitage RJ, Macduff BM, Eisenman J, et al: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483\u2013490, 1995","journal-title":"J Immunol"},{"key":"367779_CR27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.183.3.721","volume":"183","author":"MJ Leonardo","year":"1996","unstructured":"Leonardo MJ: Fas and the art of lymphocyte maintenance. J Exp Med 183:721\u2013724, 1996","journal-title":"J Exp Med"},{"key":"367779_CR28","doi-asserted-by":"crossref","first-page":"14559","DOI":"10.1073\/pnas.251540598","volume":"98","author":"N Azimi","year":"2001","unstructured":"Azimi N, Nagai M, Jacobson S, Waldmann T: Interleukin 15 is an essential factor for the persistence of the Tax-specific CD8 cells in HAM\/TSP patients. Proc Natl Acad Sci USA 98:14559\u201314564. 2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eji.1830240144","volume":"24","author":"B Sadlack","year":"1994","unstructured":"Sadlack B, Kuhn R, Schorle H, et al: Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and-4. Eur J Immunol 24:281\u2013284, 1994","journal-title":"Eur J Immunol"},{"key":"367779_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","volume":"3","author":"DM Willerford","year":"1995","unstructured":"Willerford DM, Chen J, Ferry, JA, et al: Interleukin-2 receptor ? chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521\u2013530, 1995","journal-title":"Immunity"},{"key":"367779_CR31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy MK, Glaccum M, Brown SN, et al: Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191:771\u2013780, 2000","journal-title":"J Exp Med"},{"key":"367779_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","volume":"9","author":"JP Lodolce","year":"1998","unstructured":"Lodolce JP, Boone DL, Chai S, et al: IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669\u2013676, 1998","journal-title":"Immunity"},{"key":"367779_CR33","unstructured":"Chiron Corporation Proleukin. Physicians Desk Reference: 894\u2013897, 1999"},{"key":"367779_CR34","doi-asserted-by":"crossref","first-page":"F41","DOI":"10.1084\/jem.193.11.F41","volume":"193","author":"EM Shevach","year":"2001","unstructured":"Shevach EM, Certified Professionals: CD4_ CD25_ Suppressor T cells. J Exp Med 193:F41\u2013F45, 2001","journal-title":"J Exp Med"},{"key":"367779_CR35","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.84.15.5389","volume":"84","author":"M Siekevitz","year":"1987","unstructured":"Siekevitz M, Feinberg MB, Holbrook N, et al: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the transactivator (tat) gene product of human T-cell leukemia virus Type I. Proc Natl Acad Sci USA 84:5389\u20135393, 1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR36","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1073\/pnas.95.5.2452","volume":"95","author":"N Azimi","year":"1998","unstructured":"Azimi N, Brown K, Bamford RN, et al: Human T-cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-\u03ba? site. Proc Natl Acad Sci USA 95:2452\u20132457, 1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR37","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.166.4.2602","volume":"166","author":"JM Mariner","year":"2001","unstructured":"Mariner JM, Lantz V, Waldmann TA, Azimi N: Human T cell lymphotropic virus type I Tax protein activates interleukin 15 receptor alpha gene expression through the action of NF-\u03ba?. J Immunol 166:2602\u20132609, 2001","journal-title":"J Immunol"},{"key":"367779_CR38","first-page":"6977","volume":"60","author":"KE Phillips","year":"2000","unstructured":"Phillips KE, Herring B, Wilson LA, et al: IL-2R-directed monoclonal antibodies provide effective therapy in a murine model of? adult T-cell leukemia by a mechanism other than blockade of IL-2\/IL-2R_ interaction. Cancer Res 60:6977\u20136984, 2000","journal-title":"Cancer Res"},{"key":"367779_CR39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","volume":"6","author":"RA Clynes","year":"2000","unstructured":"Clynes RA, Towers TL, Presta LG, Ravetch JV: Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 6:443\u2013446, 2000","journal-title":"Nat Med"},{"key":"367779_CR40","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1073\/pnas.86.24.10029","volume":"86","author":"C Queen","year":"1989","unstructured":"Queen C, Schneider WP, Selick HE, et al: A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci USA 86:10029\u201310033, 1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"367779_CR41","first-page":"1495","volume":"50","author":"RP Junghans","year":"1990","unstructured":"Junghans RP, Waldmann TA, Landolfi NF, et al: Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res 50:1495\u20131502, 1990","journal-title":"Cancer Res"},{"key":"367779_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","volume":"338","author":"F Vincenti","year":"1998","unstructured":"Vincenti F, Kirkman R, Light S, et al: Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. New Engl J Med 338:161\u2013165, 1998","journal-title":"New Engl J Med"},{"key":"367779_CR43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","volume":"350","author":"B Nashan","year":"1997","unstructured":"Nashan B, Moore R, Amlot P, et al: Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recepients. CHIB 201 International Study Group. Lancet 350:1193\u20131198, 1997","journal-title":"Lancet"},{"key":"367779_CR44","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.4049\/jimmunol.160.9.4418","volume":"160","author":"RN Bamford","year":"1998","unstructured":"Bamford RN, DeFilippis AP, Azimi N, et al: The 5\u2032 untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J Immunol 160:4418\u20134426, 1998","journal-title":"J Immunol"},{"key":"367779_CR45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/35636","volume":"391","author":"K Ogasawara","year":"1998","unstructured":"Ogasawara K, Hida S, Azimi N, et al: Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700\u2013703, 1998","journal-title":"Nature"},{"key":"367779_CR46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.187.6.967","volume":"187","author":"T Ohteki","year":"1998","unstructured":"Ohteki T, Yoshida H, Matsuyama T, et al: The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha\/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 187:967\u2013972, 1998","journal-title":"J Exp Med"},{"key":"367779_CR47","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","volume":"163","author":"N Azimi","year":"1999","unstructured":"Azimi N, Jacobson S, Leist T, Waldmann TA: Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2\/15R? receptor. J Immunol 163:4064\u20134072, 1999","journal-title":"J Immunol"},{"key":"367779_CR48","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.160.11.5654","volume":"160","author":"H Ruchatz","year":"1998","unstructured":"Ruchatz H, Leung BP, Wei XQ, et al: Soluble IL-15 receptor _-chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology. J Immunol 160:5654\u20135660, 1998","journal-title":"J Immunol"},{"key":"367779_CR49","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.160.12.5742","volume":"160","author":"YS Kim","year":"1998","unstructured":"Kim YS, Maslinski W, Zheng XX, et al: Targeting the IL-15 receptor with an antagonist IL-15 mutant\/Fc\u03b32a protein blocks delayed-type hypersensitivity. J. Immunol 160:5742\u20135748, 1998","journal-title":"J. Immunol"},{"key":"367779_CR50","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.4049\/jimmunol.153.9.4330","volume":"153","author":"SA Tinubu","year":"1994","unstructured":"Tinubu SA, Hakimi J, Kondas JA: Humanized antibody directed to the IL-2 receptor ?-chain prolongs primate cardiac allograft survival. J Immunol 153:4330\u20134338, 1994","journal-title":"J Immunol"},{"key":"367779_CR51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4049\/jimmunol.151.2.1075","volume":"151","author":"J Hakimi","year":"1993","unstructured":"Hakimi J, Ha VC, Lin P, et al: Humanized Mik? 1, a humanized antibody to the IL-2 receptor ?-chain that acts synergistically with humanized anti-Tac. J Immunol 151:1075\u20131085, 1993","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014416616687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014416616687\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014416616687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T13:25:26Z","timestamp":1751030726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014416616687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["367779"],"URL":"https:\/\/doi.org\/10.1023\/a:1014416616687","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}